SEARCH

SEARCH BY CITATION

Current Awareness

  • 1. Reviews
  • Proceedings of the 1st International Conference on Molecular Imaging Technology EuroMedIm 2006, Marseille, France, 9-12 May, 2006. Nucl Instrum Methods Phys Res A 571, (2007)
  • Special issue: Imaging mass spectrometry (Principally on biological systems). Int J Mass Spectrom 260,
  • Aznavour N, Zimmer L. [18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain. Neuropharmacology 52, 695-707 (2007)
  • Beer AJ, Schwaiger M. Molecular imaging with new PET tracers (German, English Abstract). Radiologe 47, 8-17 (2007)
  • Bertolotto M, Bartolotta TV, Belgrano M, Trincia E, Cernic S, Zappetti R, Cova MA. Detection of liver metastases with contrast enhanced ultrasonography. Curr Med Imaging Rev 3, 37-44 (2007)
  • Blomley M, Claudon M, Cosgrove D. WFUMB safety symposium on ultrasound contrast agents: Clinical applications and safety concerns. Ultrasound Med Biol 33, 180-186 (2007)
  • Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F. New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39, 187-195 (2007)
  • Bouakaz A, De Jong N. WFUMB safety symposium on echo-contrast agents: Nature and types of ultrasound contrast agents. Ultrasound Med Biol 33, 187-196 (2007)
  • Burgstahler C, Hombach V, Rasche V. Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging. Semin Thromb Hemost 33, 165-172 (2007)
  • Camacho V, Carrio I. Targeting neuronal dysfunction and receptor imaging. Curr Opin Biotechnol 18, 60-64 (2007)
  • Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol 18, 26-30 (2007)
  • Choi SH, Chae A, Chen CH, Merki E, Shaw PX, Tsimikas S. Emerging approaches for imaging vulnerable plaques in patients. Curr Opin Biotechnol 18, 73-82 (2007)
  • Corsten MF, Reutelingsperger CPM, Hofstra L. Imaging apoptosis for detecting plaque instability: Rendering death a brighter facade. Curr Opin Biotechnol 18, 83-89 (2007)
  • Dalecki D. WFUMB safety symposium on echo-contrast agents: Bioeffects of ultrasound contrast agents in vivo. Ultrasound Med Biol 33, 205-213 (2007)
  • Dobrucki LW, Sinusas AJ. Imaging angiogenesis. Curr Opin Biotechnol 18, 90-96 (2007)
  • Essig M, Nikolaou K, Meaney JFM. Magnetic resonance angiography of the head and neck vessels. Eur Radiol 17, B30-B37 (2007)
  • Fink C, Goyen M, Lotz J. Magnetic resonance angiography with blood-pool contrast agents: Future applications. Eur Radiol 17, B38-B44 (2007)
  • Giovagnoni A, Catalano C. Application of blood-pool agents in visualization of peripheral vessels. Eur Radiol 17, B18-B23 (2007)
  • Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol 18, 11-16 (2007)
  • Kimura Y, Naganawa M, Shidahara M, Ikoma Y, Watabe H. PET kinetic analysis - Pitfalls and a solution for the Logan plot. Ann Nucl Med 21, 1-8 (2007)
  • Kramer H, Morana G. Whole-body magnetic resonance angiography with blood-pool agents. Eur Radiol 17, B24-B29 (2007)
  • Leiner T, Schoenberg SO. Current status of renal artery magnetic resonance imaging: Theoretical and practical considerations and the potential role of blood-pool contrast agents. Eur Radiol 17, B13-B17 (2007)
  • Mankoff DA, O'Sullivan F, Barlow WE, Krohn KA. Molecular imaging research in the outcomes era: Measuring outcomes for individualized cancer therapy. Acad Radiol 14, 398-405 (2007)
  • Massoud TF, Paulmurugan R, De AJ, Ray P, Garnbhir SS. Reporter gene imaging of protein-protein interactions in living subjects. Curr Opin Biotechnol 18, 31-37 (2007)
  • Matuszewski L, Tombach B, Heindel W, Bremer C. Molecular and parametric imaging with iron oxides (German, English Abstract). Radiologe 47, 34-42 (2007)
  • McLarty K, Reilly RM. Molecular imaging as a tool for personalized and targeted anticancer therapy. Clin Pharmacol Ther 81, 420-424 (2007)
  • Meaney JFM, Goyen M. Recent advances in contrast-enhanced magnetic resonance angiography. Eur Radiol 17, B2-B6 (2007)
  • Miller DL. WFUMB safety symposium on echo-contrast agents: In vitro bioeffects. Ultrasound Med Biol 33, 197-204 (2007)
  • Nahrendorf M, Weissleder R. Advances in cardiovascular medicine through molecular imaging (German, English Abstract). Radiologe 47, 18-24 (2007)
  • Nyborg W. WFUMB safety symposium on echo-contrast agents: Mechanisms for the interaction of ultrasound. Ultrasound Med Biol 33, 224-232 (2007)
  • Rao J, Dragulescu-Andrasi A, Yao HQ. Fluorescence imaging in vivo: Recent advances. Curr Opin Biotechnol 18, 17-25 (2007)
  • Rohrer M, Geerts-Ossevoort L, Laub G. Technical requirements, biophysical considerations and protocol optimization with magnetic resonance angiography using blood-pool agents. Eur Radiol 17, B7-B12 (2007)
  • Rollandi GA, Biscaldi E, DeCicco E. Double contrast barium enema: Technique, indications, results and limitations of a conventional imaging methodology in the MDCT virtual endoscopy era. Eur J Radiol 61, 382-387 (2007)
  • Schaller BJ, Modo M, Buchfelder M. Molecular imaging of brain tumors: A bridge between clinical and molecular medicine?. Mol Imaging Biol 9, 60-71 (2007)
  • Shirani J, Dilsizian V. Molecular imaging in heart failure. Curr Opin Biotechnol 18, 65-72 (2007)
  • Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 18, 4-10 (2007)
  • Sundin A, Garske U, Orlefors H. Nuclear imaging of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21, 69-85 (2007)
  • Swijnenburg RJ, Van der Bogt KEA, Sheikh AY, Cao F, Wu JC. Clinical hurdles for the transplantation of cardiomyocytes derived from human embryonic stem cells: Role of molecular imaging. Curr Opin Biotechnol 18, 38-45 (2007)
  • Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J Magn Reson Imaging 25, 667-680 (2007)
  • Yoshinaga K, Tamaki N. Imaging myocardial metabolism. Curr Opin Biotechnol 18, 52-59 (2007)
  • Contrast Agents: 3. Chemistry
  • Ashcroft JM, Hartman KB, Kissell KR, Mackeyev Y, Pheasant S, Young S, Van der Heide PAW, Mikos AG, Wilson LJ. Single-molecule I2@US-tube nanocapsules: A new X-ray contrast-agent design. Adv Mater 19, 573-576 (2007)
  • Barge A, Cravotto G, Robaldo B, Gianolio E, Aime S. New CD derivatives as self-assembling contrast agents for magnetic resonance imaging (MRI). J Inclusion Phenom Macrocycl Chem 57, 489-495 (2007)
  • Di Marco M, Guilbert I, Port M, Robic C, Couvreur P, Dubernet C. Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. Int J Pharm 331, 197-203 (2007)
  • Hettiarachchi K, Talu E, Longo ML, Dayton PA, Lee AP. On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip 7, 463-468 (2007)
  • Jaszberenyi Z, Moriggi L, Schmidt P, Weidensteiner C, Kneuer R, Merbach AE, Helm L, Toth E. Physicochemical and MRI characterization of Gd3+-loaded polyamidoamine and hyperbranched dendrimers. J Biol Inorg Chem 12, 406-420 (2007)
  • Laurent S, Elst LV, Vroman A, Muller RN. Synthesis and physicochemical characterization of new C-functionalized derivatives of the gadolinium(III) complex with 3,6,10-tris(carboxymethyl)-3,6,10-triazadodecanedioic acid (H5ttda) exhibiting fast water exchange potential paramagnetic reporters for molecular imaging. Helv Chim Acta 90, 562-573 (2007)
  • Li ZF, Li WS, Li XJ, Pei FK, Li YX, Lei H. The gadolinium complexes with polyoxometalates as potential MRI contrast agents. Magn Reson Imaging 25, 412-417 (2007)
  • Lisy MR, Hartung A, Lang C, Schuler D, Richter W, Reichenbach JR, Kaiser WA, Hilger I. Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents. Invest Radiol 42, 235-241 (2007)
  • Postema M, Schmitz G. Ultrasonic bubbles in medicine: Influence of the shell. Ultrason Sonochemistry 14, 438-444 (2007)
  • Prasuhn DE, Yeh RM, Obenaus A, Manchester M, Finn MG. Viral MRI contrast agents: Coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition. Chem Commun 1269-1271 (2007)
  • Rodriguez E, Simoes RV, Roig A, Molins E, Nedelko N, Slawska-Waniewska A, Aime S, Arus C, Cabanas ME, Sanfeliu C, Cerdan S, Garcia-Martin ML. An iron-based T1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies. MAGMA 20, 27-37 (2007)
  • Shultz MD, Calvin S, Fatouros PP, Morrison SA, Carpenter EE. Enhanced ferrite nanoparticles as MRI contrast agents. J Magn Magn Mater 311, 464-468 (2007)
  • Taboada E, Rodriguez E, Roig A, Oro J, Roch A, Muller RN. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir 23, 4583-4588 (2007)
  • Tu CQ, Louie AY. Photochromically-controlled, reversibly-activated MRI and optical contrast agent. Chem Commun 1331-1333 (2007)
  • 4. Technique
  • Backer MV, Levashova Z, Patel V, Jehning BT, Claffey K, Blankenberg FG, Backer JM. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med 13, 504-509 (2007)
  • Caruso G, Martegani A, Aiani L, Borghi C, Verderame F, Campisi A, Salvaggio G, Lagalla R, Cardinale AE. Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: A new hypothesis. Radiol Med (Torino) 112, 56-63 (2007)
  • Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, Harmelin A, Benjamin LE, Neeman M. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 13, 498-503 (2007)
  • Edelman RR, Storey P, Dunkle E, Li W, Carrillo A, Vu A, Carroll TJ. Gadolinium-enhanced off-resonance contrast angiography. Magn Reson Med 57, 475-484 (2007)
  • Funovics M. Optical imaging of fluorescence in the near infrared. From passive to enzymatically activated contrast medium (German, English Abstract). Radiologe 47, 53-61 (2007)
  • Hashagen C, Schulte AC, Bongartz G, Aschwanden M, Jaeger KA, Huegli R, Jacob AL, Bilecen D. Effect of bolus length of intraarterial injections on contrast-enhanced MR-angiography in patients. J Magn Reson Imaging 25, 841-847 (2007)
  • Henning TD, Saborowski O, Golovko D, Boddington S, Bauer JS, Fu YJ, Meier R, Pietsch H, Sennino B, McDonald DM, Daldrup-Link HE. Cell labeling with the positive MR contrast agent Gadofluorine M. Eur Radiol 17, 1226-1234 (2007)
  • Ho LM, Merkle EM, Paulson EK, Dale BM. Contrast-enhanced hepatic magnetic resonance angiography at 3 T: Does parallel imaging improve image quality?. J Comput Assist Tomogr 31, 177-180 (2007)
  • Johnson TRC, Nikolaou K, Wintersperger BJ, Fink C, Rist C, Leber AW, Knez A, Reiser MF, Becker CR. Optimization of contrast material administration for electrocardiogram-gated computed tomographic angiography of the chest. J Comput Assist Tomogr 31, 265-271 (2007)
  • Jourdan C, Heverhagen JT, Knopp MV. Dose comparison of single- vs. double-dose in contrast-enhanced resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA. J Magn Reson Imaging 25, 557-563 (2007)
  • Kallioniemi AS, Jurvelin JS, Nieminen MT, Lammi MJ, Toyras J. Contrast agent enhanced pQCT of articular cartilage. Phys Med Biol 52, 1209-1219 (2007)
  • Kanematsu M, Goshima S, Kondo H, Tsuge Y, Yokoyama R, Kajita K, Onozuka M, Suzuki Y, Van Cauteren M, Moriyama N. Gadolinium-enhanced multiphasic 3D MRI of the liver with prospective adaptive navigator correction: Phantom study and preliminary clinical evaluation. Am J Roentgenol 188, W309-W316 (2007)
  • Koenig MJ, Torp-Pedersen S, Holmich P, Terslev L, Nielsen MB, Boesen M, Bliddal H. Ultrasound Doppler of the Achilles tendon before and after injection of an ultrasound contrast agent - Findings in asymptomatic subjects (German, English Abstract). Ultraschall Med 28, 52-56 (2007)
  • Kotys MS, Akbudak E, Markham J, Conturo TE. Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI. J Magn Reson Imaging 25, 598-611 (2007)
  • Li W, Salanitri J, Tutton S, Dunkle EE, Schneider JR, Caprini JA, Pierchala LN, Jacobs PM, Edelman RR. Lower extremity deep venous thrombosis: Evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism preliminary experience. Radiology 242, 873-881 (2007)
  • Mahnken AH, Rauscher A, Klotz E, Muhlenbruch G, Das M, Gunther RW, Wildberger JE. Quantitative prediction of contrast enhancement from test bolus data in cardiac MSCT. Eur Radiol 17, 1310-1319 (2007)
  • Meindl TM, Hagl E, Reiser MF, Mueller-Lisse UG. Comparison of 2 different protocols for ingestion of low-attenuating oral contrast agent for multidetector computed tomography of the abdomen. J Comput Assist Tomogr 31, 218-222 (2007)
  • Miles KA, Young H, Chica SL, Esser PD. Quantitative contrast-enhanced computed tomography: Is there a need for system calibration?. Eur Radiol 17, 919-926 (2007)
  • Nagaraja TN, Nagesh V, Ewing JR, Whitton PA, Fenstermacher JD, Knight RA. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections. Magn Reson Imaging 25, 311-318 (2007)
  • Namkung S, Zech CJ, Heimberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: Efficacy for characterization of focal liver lesions. J Magn Reson Imaging 25, 755-765 (2007)
  • Numburi UD, Chatzimavroudis GP, Stillman AE, Lieber ML, Uber AE, Kalafut JF, White RD, Halliburton SS. Patient-specific contrast injection protocols for cardiovascular multidetector row computed tomography. J Comput Assist Tomogr 31, 281-289 (2007)
  • Schaefer FKW, Schaefer PJ, Altjohann C, Bourne M, DeCobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, Oberholzer K, Pering C, Poeckler-Schoeninger C, Ruehm SG, Sachoran MR, Schulte-Altedorneburg G, Springer OS, Steiner P, Wall A, Winterer J, Tombach B. A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0 M gadobutrol (Gadovist™) to intraarterial digital subtraction angiography in body arteries. Eur J Radiol 61, 315-323 (2007)
  • Shapiro EM, Medford-Davis LN, Fahmy TM, Dunbar CE, Koretsky AP. Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol Imaging 2, 147-153 (2007)
  • Sirineni GKR, Kalra MK, Pottala K, Waldrop S, Syed M, Tigges S. Effect of contrast concentration, tube potential and reconstruction kernels on MDCT evaluation of coronary stents: An in vitro study. Int J Cardiovasc Imaging 23, 253-263 (2007)
  • Tanaka YO, Ohtsuka S, Shindo M, Oyake Y, Minami M. Comparison of delayed myocardial enhancement in the early and late phase after contrast injection: Is it possible to reduce the examination time for myocardial viability study?. Magn Reson Imaging 25, 232-237 (2007)
  • Terae S, Yoshida D, Kudo K, Tha KK, Fujino M, Miyasaka K. Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: Usefulness in the evaluation of brain metastases. J Magn Reson Imaging 25, 479-487 (2007)
  • Tiderius CJ, Jessel R, Kim YJ, Burstein D. Hip dGEMRIC in asymptomatic volunteers and patients with early osteoarthritis: The influence of timing after contrast injection. Magn Reson Med 57, 803-805 (2007)
  • Treier R, Steingoetter A, Fried M, Schwizer W, Boesiger P. Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med 57, 568-576 (2007)
  • Von Falkenhausen M, Meyer C, Lutterbey G, Morakkabati N, Walter O, Gieseke J, Blomer R, Willinek WA, Kuhl CK, Schild HH. Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. Eur Radiol 17, 1256-1261 (2007)
  • Wessig C, Bendszus M, Stoll G. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging. Exp Neurol 204, 14-19 (2007)
  • Whittingham TA. WFUMB safety symposium on echo-contrast agents: Exposure from diagnostic ultrasound equipment relating to cavitation risk. Ultrasound Med Biol 33, 214-223 (2007)
  • Woods BJ, Clymer BD, Kurc T, Heverhagen JT, Stevens R, Orsdemir A, Bulan O, Knopp MV. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data. J Magn Reson Imaging 25, 495-501 (2007)
  • Yamamuro M, Tadamura E, Kanao S, Wu YW, Tambara K, Komeda M, Toma M, Kimura T, Kita T, Togashi K. Coronary angiography by 64-detector row computed tomography using low dose of contrast material with saline chaser: Influence of total injection volume on vessel attenuation. J Comput Assist Tomogr 31, 272-280 (2007)
  • Yukisawa S, Okugawa H, Masuya Y, Okabe S, Fukuda H, Yoshikawa M, Ebara M, Saisho H. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: A comparison with multi-phase CT during hepatic arteriography. Eur J Radiol 61, 279-289 (2007)
  • 5. Experimental
  • Braun RD, Gradianu M, Vistisen KS, Roberts RL, Berkowitz BA. Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci 48, 963-967 (2007)
  • Brodoefel H, Reimann A, Klumpp B, Fenchel M, Ohmer M, Miller S, Schroeder S, Claussen C, Scheule A, Kopp AF. Assessment of myocardial viability in a reperfused porcine model: Evaluation of different MSCT contrast protocols in acute and subacute infarct stages in comparison with MRI. J Comput Assist Tomogr 31, 290-298 (2007)
  • Cicchetti F, Gross RE, Bulte JWM, Owen M, Chen I, Saint-Pierre M, Wang X, Yu M, Brownell AL. Dual-modality in vivo monitoring of subventricular zone stem cell migration and metabolism. Contrast Media Mol Imaging 2, 130-138 (2007)
  • Hilger I, Trost R, Reichenbach JR, Linss W, Lisy MR, Berndt A, Kaiser WA. MR imaging of Her-2/neu protein using magnetic nanoparticles. Nanotechnology 18, 135103 (2007)
  • Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CAS, Brechbiel MW, Choyke PL, Kobayashi H. A dendrimer-based nanosized contrast agent, dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging 25, 866-871 (2007)
  • Lazaro FJ, Gutierrez L, Abadia AR, Romero MS, Lopez A, Munoz MJ. Whole tissue AC susceptibility after superparamagnetic iron oxide contrast agent administration in a rat model. J Magn Magn Mater 311, 460-463 (2007)
  • Lu HB, Xi ZX, Gitajn L, Rea W, Yang YH, Stein EA. Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI). Proc Natl Acad Sci U S A 104, 2489-2494 (2007)
  • Luo W, Zhou XD, Ren XL, Zheng MJ, Zhang J, He GB. Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo. J Ultrasound Med 26, 469-476 (2007)
  • Meding J, Urich M, Licha K, Reinhardt M, Misselwitz B, Fayad ZA, Weinmann HJ. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. Contrast Media Mol Imaging 2, 120-129 (2007)
  • Peukert D, Kaufels N, Laule M, Schnorr J, Carme S, Farr T, Schonenberger E, Taupitz M, Hamm B, Dewey M. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent P792 in a nonreperfused porcine infarction model. Invest Radiol 42, 248-255 (2007)
  • Pollard RE, Broumas AR, Wisner ER, Vekich SV, Ferrara KW. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol 33, 235-245 (2007)
  • Sitharaman B, Tran LA, Pham QP, Bolskar RD, Muthupillai R, Flamm SD, Mikos AG, Wilson LJ. Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast Media Mol Imaging 2, 139-146 (2007)
  • Tsuda N, Okada M, Murakami T. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol 42, 242-247 (2007)
  • Van der Zijden JP, Wu O, Van der Toorn A, Roeling TP, Bleys RLAW, Dijkhuizen RM. Changes in neuronal connectivity after stroke in rats as studied by serial manganese-enhanced MRI. Neuroimage 34, 1650-1657 (2007)
  • Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang DH, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 25, 319-327 (2007)
  • Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33, 318-325 (2007)
  • Yen HW, Lee HC, Lai WT, Sheu SH. Effects of acetylcysteine and probucol on contrast medium-induced depression of intrinsic renal glutathione peroxidase activity in diabetic rats. Arch Med Res 38, 291-296 (2007)
  • 6. ApplicationsMolecular Imaging:
  • Boss A, Martirosian P, Gehrmann M, Artunc F, Risler T, Oesingmann N, Claussen CD, Schick F, Kuper K, Schlemmer HP. Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: A phase 1 trial. Radiology 242, 783-790 (2007)
  • Catalano O, Sandomenico F, Nunziata A, Raso MM, Vallone P, Siani A. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography - Sonographic sign and pitfall. J Ultrasound Med 26, 337-345 (2007)
  • Koh DM, Brown G, Meer Z, Norman AR, Husband JE. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. Am J Roentgenol 188, W154-W161 (2007)
  • Kuhn MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: Intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention. J Neurosurg 106, 557-566 (2007)
  • Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: Value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 25, 848-858 (2007)
  • Marin D, Iannaccone R, Laghi A, Catalano C, Murakami T, Hori M, Kim T, Passariello R. Focal nodular hyperplasia: Intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 25, 775-782 (2007)
  • Mell M, Tefera G, Thornton F, Siepman D, Turnipseed W. Clinical utility of time-resolved imaging of contrast kinetics (TRICK-S) magnetic resonance angiography for infrageniculate arterial occlusive disease. J Vasc Surg 45, 543-548 (2007)
  • Mende KA, Froehlich JM, Von Weymarn C, Hoogeveen R, Kistler T, Zollikofer CL, Wentz KU. Time-resolved, high-resolution contrast-enhanced MR angiography of dialysis shunts using the CENTRA keyhole technique with parallel imaging. J Magn Reson Imaging 25, 832-840 (2007)
  • Neuwelt EA, Varallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: A pilot study. Neurosurgery 60, 601-611 (2007)
  • Park MS, Yu JS, Lee DK, Yoon DS, Cha SW, Kim KW. Gadobenate dimeglumine-enhanced MRI of intraductal papillary mucinous tumor of the bile ducts. J Magn Reson Imaging 25, 625-627 (2007)
  • Pavlovic C, Futamatsu H, Angiolillo DJ, Guzman LA, Wilke N, Siragusa D, Wfudyka P, Percy R, Northrup M, Bass TA, Costa MA. Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: A comparative study versus standard digital angiography. Int J Cardiovasc Imaging 23, 225-232 (2007)
  • Prantl L, Pfister K, Kubale R, Schmitt S, Stockhammer V, Jung W, Zorger N, Herold T, Nerlich M, Stehr A, Jung EM. Value of high resolution ultrasound and contrast enhanced US pulse inversion imaging for the evaluation of the vascular integrity of free-flap grafts. Clin Hemorheol Microcirc 36, 203-216 (2007)
  • Rees JD, Pilcher J, Heron C, Kiely PDW. A comparison of clinical vs ultrasound determined synovitis in rheumatoid arthritis utilizing gray-scale, power Doppler and the intravenous microbubble contrast agent ‘Sono-Vue’®. Rheumatology 46, 454-459 (2007)
  • Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi FM, Trippa F, Calascibetta F, Erturk SM, Modesti M, Passariello R. Benign and malignant breast lesions: Efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging (German, English Abstract). Ultraschall Med 28, 57-62 (2007)
  • Tizon X, Lin QF, Hansen T, Borgefors G, Johansson L, Ahlstrom H, Frimmel H. Identification of the main arterial branches by whole-body contrast-enhanced MRA in elderly subjects using limited user interaction and fast marching. J Magn Reson Imaging 25, 806-814 (2007)
  • Uysal E, Erturk SM, Yildirim H, Seleker F, Basak M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. Am J Roentgenol 188, 697-702 (2007)
  • Vincensini D, Dedieu V, Eliat PA, Vincent C, Bailly C, De Certaines J, Joffre F. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry. Magn Reson Imaging 25, 293-302 (2007)
  • 7. Carbon
  • Bourdier T, Poisnel G, Dhilly M, Delamare J, Henry J, Debruyne D, Barre L. Synthesis and biological evaluation of N-substituted quinolinimides, as potential ligands for in vivo imaging studies of δ-opioid receptors. Bioconjug Chem 18, 538-548 (2007)
  • Cleij MC, Clark JC, Baron JC, Aigbirhio FI. Rapid preparation of (11C)flumazenil: Captive solvent synthesis combined with purification by analytical sized columns. J Label Compound Radiopharm 50, 19-24 (2007)
  • Esposito G, Giovacchini G, Der M, Liow JS, Bhattacharjee AK, Ma K, Herscovitch P, Channing M, Eckelman WC, Hallett M, Carson RE, Rapoport SI. Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage 34, 1342-1351 (2007)
  • Ginovart N, Willeit M, Rusjan P, Graff A, Bloomfield PM, Houle S, Kapur S, Wilson AA. Positron emission tomography quantification of [11C]-(+)-PNHO binding in the human brain. J Cereb Blood Flow Metab 27, 857-871 (2007)
  • Henriksen G, Hauser AI, Westwell AD, Yousefi BH, Schwaiger M, Drzezga A, Wester HJ. Metabolically stabilized benzothiazoles for imaging of amyloid plaques. J Med Chem 50, 1087-1089 (2007)
  • Kil KE, Ding YS, Lin KS, Alexoff D, Kim SW, Shea C, Xu Y, Muench L, Fowler JS. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). Nucl Med Biol 34, 153-163 (2007)
  • Lundquist P, Hartvig P, Blomquist G, Hammarlund-Udenaes M, Langstrom B. 5-hydroxy-L-[β-11C]tryptophan versus α-[11C]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain. J Cereb Blood Flow Metab 27, 821-830 (2007)
  • Lundquist P, Roman M, Syvanen S, Hartvig P, Blomquist G, Hammarlund-Udenaes M, Langstrom B. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: Positron emission tomography studies in monkeys and rats. Synapse 61, 440-449 (2007)
  • Pedersen K, Simonsen M, Ostergaard SD, Lajord Munk O, Rosa-Neto P, Olsen AK, Jensen SB, Moller A, Cumming P. Mapping the amphetamine-evoked changes in [11C] raclopride binding in living rat using small animal PET: Modulation by MAO-inhibition. Neuroimage 35, 38-46 (2007)
  • Sakata M, Kimura Y, Naganawa M, Oda K, Ishii K, Chihara K, Ishiwata K. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C] SA4503. Neuroimage 35, 1-8 (2007)
  • Sibon I, Strafella AP, Gravel P, Ko JH, Booji L, Soucy JP, Leyton M, Diksic M, Benkelfat C. Acute prefrontal cortex TMS in healthy volunteers: Effects on brain 11C-αMtrp trapping. Neuroimage 34, 1658-1664 (2007)
  • Takano A, Ito H, Arakawa R, Saijo T, Suhara T. Effects of the reference tissue setting on the parametric image of 11C-WAY 100635. Nucl Med Commun 28, 193-198 (2007)
  • 8. Fluorine
  • Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Biodistribution and PET imaging of [18F] -fluoroadenosine derivatives. Nucl Med Biol 34, 267-272 (2007)
  • Beauregard JM, Croteau E, Ahmed N, Ouellette R, Van Lier JE, Benard F. Effective specific activities determined by scintillation proximity counting for production runs of [18F]FES and 4F-M[18F]FES. Nucl Med Biol 34, 325-329 (2007)
  • Chitneni SK, Deroose CM, Balzarini J, Gijsbers R, Celen SJL, De Groot TJ, Debyser Z, Mortelmans L, Verbruggen AM, Bormans GM. Synthesis and preliminary evaluation of 18F- or 11C-Labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography. J Med Chem 50, 1041-1049 (2007)
  • Ciernik IF, Brown DW, Schmid D, Hany T, Egli P, Davis JB. 3D-Segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate. Technol Cancer Res Treat 6, 23-30 (2007)
  • Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Nucl Med Commun 28, 273-280 (2007)
  • Gollub MJ, Akhurst T, Markowitz AJ, Weiser MR, Guillem JG, Smith LM, Larson SM, Margulis AR. Combined CT colonography and 18F FDG PET of colon polyps: Potential technique for selective detection of cancer and precancerous lesions. Am J Roentgenol 188, 130-138 (2007)
  • Hamazawa Y, Koyama K, Okamura T, Wada Y, Wakasa T, Okuma T, Watanabe Y, Inoue Y. Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model. Ann Nucl Med 21, 47-55 (2007)
  • Hattori Y, Yamamoto H, Ando H, Kondoh H, Asano T, Kirihata M, Yamaguchi Y, Wakamiya T. Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative. Bioorg Med Chem 15, 2198-2205 (2007)
  • Kaneta T, Takai Y, Iwata R, Hakamatsuka T, Yasuda H, Nakayama K, Ishikawa Y, Watanuki S, Furumoto S, Funaki Y, Nakata E, Jingu K, Tsujitani M, Ito M, Fukuda H, Takahashi S, Yamada S. Initial evaluation of dynamic human imaging using 18F-FRP170 as a new PET tracer for imaging hypoxia. Ann Nucl Med 21, 101-107 (2007)
  • Khandani AH, Whitney KD, Keller SM, Isasi CR, Blaufox MD. Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer. Nucl Med Commun 28, 173-177 (2007)
  • Kiesewetter DO, Jagoda EM, Shimoji K, Ma Y, Eckelman WC. Evaluation of [18F]fluoroxanomeline {5-{4-[(6-[18F]fluorohexyl)oxy]-1 2, 5-thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydropyridine} in Muscarinic knockout mice. Nucl Med Biol 34, 141-152 (2007)
  • Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF. Pharmacokinetics of {18F} fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol 34, 233-237 (2007)
  • Kumano H, Ida I, Oshima A, Takahashi K, Yuuki N, Amanuma M, Oriuchi N, Endo K, Matsuda H, Mikuni M. Brain metabolic changes associated with predisposition to onset of major depressive disorder and adjustment disorder in cancer patients - A preliminary PET study. J Psychiatr Res 41, 591-599 (2007)
  • Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nucl Med Biol 34, 239-246 (2007)
  • Lee BC, Lee KC, Lee H, Mach RH, Katzenellenbogen JA. Synthesis and binding affinity of a fluorine-substituted peroxisome proliferator-activated gamma; (PPARγ) ligand as a potential positron emission tomography (PET) imaging agent. Bioconjug Chem 18, 507-513 (2007)
  • Lee BC, Lee KC, Lee H, Mach RH, Katzenellenbogen JA. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor γ ligands: Potential positron emission tomography and single photon emission computed tomography imaging agents. Bioconjug Chem 18, 514-523 (2007)
  • Marik J, Tartis MS, Zhang H, Fung JY, Kheirolomoom A, Sutcliffe JL, Ferrara KW. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol 34, 165-171 (2007)
  • Matsumoto KI, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, Carson J, Sowers AL, English S, Green MV, Bacharach SL, Eckelman WC, Mitchell JB. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]fluoromisonidazole positron emission tomography. Int J Oncol 30, 873-881 (2007)
  • Nyman MJ, Eskola O, Kajander J, Vahlberg T, Sanabria S, Burns D, Hargreaves R, Solin O, Hietala J. Gender and age affect NK1 receptors in the human brain - A positron emission tomography study with [18F]SPA-RQ. Int J Neuropsychopharmacol 10, 219-229 (2007)
  • Parent EE, Dence CS, Jenks C, Sharp TL, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging. J Med Chem 50, 1028-1040 (2007)
  • Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43, 557-564 (2007)
  • Ponde DE, Dence CS, Oyama N, Kim J, Tai YC, Laforest R, Siegel BA, Welch MJ. 18F-fluoroacetate: A potential acetate analog for prostate tumor imaging - In vivo evaluation of 18F-fluoroacetate versus11C-acetate. J Nucl Med 48, 420-428 (2007)
  • Prante O, Hamacher K, Coenen HH. Chemoenzymatic n.c.a synthesis of the coenzyme UDP-2-deoxy-2-(18F)fluoro-α-D-glucopyranose as substrate of glycosyltransferases. J Label Compound Radiopharm 50, 55-63 (2007)
  • Prante O, Blaser D, Maschauer S, Kuwert T. In vitro characterization of the thyroidal uptake of O-(2-[18F]fluoroethyl)-L-tyrosine. Nucl Med Biol 34, 305-314 (2007)
  • Sheehan JJ, Ridge CA, Ward EVM, Duffy GJ, Collins CD, Skehan SJ, Malone DE. FDG PET in preoperative assessment of colorectal liver metastases combining “evidence-based practice” and “technology assessment” methods to develop departmental imaging protocols: Should FDG PET be routinely used in the preoperative assessment of patients with colorectal liver metastases?. Acad Radiol 14, 389-397 (2007)
  • Shumway DA, Pavlova OA, Mukhin AG. A simplified method for the measurement of nonmetabolized 2-[18F]F-A-85380 in blood plasma using solid-phase extraction. Nucl Med Biol 34, 221-228 (2007)
  • Sihver W, Drewes B, Schulze A, Olsson RA, Coenen HH. Evaluation of novel tropane analogues in comparison with the binding characteristics of [18F]FP-CIT and [131I] β-CIT. Nucl Med Biol 34, 211-219 (2007)
  • Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O. Measurement of the α4β2* nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 and its metabolites in human blood during PET investigation: A methodological study. Nucl Med Biol 34, 331-342 (2007)
  • Takasawa M, Beech JS, Fryer TD, Hong YT, Hughes JL, Igase K, Jones PS, Smith R, Aigbirhio FI, Menon DK, Clark JC, Baron JC. Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: A pilot study. J Cereb Blood Flow Metab 27, 679-689 (2007)
  • Tayama Y, Takahashi N, Oka T, Takahashi A, Aratake M, Saitou T, Inoue T. Clinical evaluation of the effect of attenuation correction technique on 18F-fluoride PET images. Ann Nucl Med 21, 93-99 (2007)
  • Thie JA, Hubner KF, Isidoro FP, Smith GT. A weight index for the standardized uptake value in 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 9, 91-98 (2007)
  • Tsuchida T, Okazawa H, Mori T, Kobayashi M, Yoshida Y, Fujibayashi Y, Itoh H. In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET - Influence of menstrual cycle and endogenous estrogen level. Nucl Med Biol 34, 205-210 (2007)
  • Van Kuyck K, Casteels C, Vermaelen P, Bormans G, Nuttin B, Van Laere K. Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: A voxel-based microPET study. Neuroimage 35, 214-221 (2007)
  • Vasdev N, Seeman P, Garcia A, Stableford WT, Nobrega JN, Houle S, Wilson AA. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: Radiosynthesis, ex vivo biodistribution and autoradiography of [18F]F-PHNO. Nucl Med Biol 34, 195-203 (2007)
  • Vaupel DB, Stein EA, Mukhin AG. Quantification of α4β2* nicotinic receptors in the rat brain with microPET® and 2-[18F]F-A-85380. Neuroimage 34, 1352-1362 (2007)
  • Wang YB, Chiu E, Rosenberg J, Gambhir SS. Standardized uptake value atlas: Characterization of physiological 2-deoxy-2-[18F]fluoro-D-glucose uptake in normal tissues. Mol Imaging Biol 9, 83-90 (2007)
  • Wolz G, Nomayr A, Hothorn T, Hornegger J, Romer W, Bautz W, Kuwert T. Anatomical accuracy of interactive and automated rigid registration between X-ray CT and FDG-PET. Nuklearmedizin 46, 43-48 (2007)
  • 10. Hydrogen
  • Adriani W, Canese R, Podo F, Laviola G. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol Teratol 29, 116-125 (2007)
  • Glodzik-Sobanska L, Li J, Mosconi L, Slowik A, Walecki J, Szczudlik A, Sobiecka B, De Leon MJ. Prefrontal N-acetylaspartate and poststroke recovery: A longitudinal proton spectroscopy study. Am J Neuroradiol 28, 470-474 (2007)
  • Grande S, Luciani AM, Rosi A, Palma A, Giovannini C, Sapora O, Guidoni L, Viti V. Metabolism of glutathione in tumour cells as evidenced by 1H MRS. FEBS Lett 581, 637-643 (2007)
  • Guzman-de-Villoria JA, Sanchez-Gonzalez J, Munoz L, Reig S, Benito C, Garcia-Barreno P, Desco M. 1H MR spectroscopy in the assessment of gliomatosis cerebri. Am J Roentgenol 188, 710-714 (2007)
  • Ham BJ, Sung Y, Kim N, Kim SJ, Kim JE, Kim DJ, Lee JY, Kim JH, Yoon SJ, Lyoo IK. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: A proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry 31, 403-411 (2007)
  • Harada K, Honmou O, Liu H, Bando M, Houkin K, Kocis JD. Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occulsion model. Brain Res 1134, 206-213 (2007)
  • Kimura T, Ohkubo M, Igarashi H, Kwee IL, Nakada T. Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: A 3.0-Tesla proton magnetic resonance spectroscopy study. J Neurosurg 106, 609-613 (2007)
  • Koch KM, Sacolick LI, Nixon TW, McIntyre S, Rothman DL, De Graaf RA. Dynamically shimmed multivoxel 1H magnetic resonance spectroscopy and multislice magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 57, 587-591 (2007)
  • Lange T, Trabesinger AH, Schulte RF, Dydak U, Boesiger P. Prostate spectroscopy at 3 Tesla using two-dimensional S-PRESS. Magn Reson Med 56, 1220-1228 (2006)
  • Martin FPJ, Wang YL, Sprenger N, Holmes E, Lindon JC, Kochhar S, Nicholson JK. Effects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopy. J Proteome Res 6, 1471-1481 (2007)
  • Meyerspeer M, Kemp GJ, Mlynarik V, Krssak M, Szendroedi J, Nowotny P, Roden M, Moser E. Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Magn Reson Med 57, 654-680 (2007)
  • Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Paul H, Randall E, Lyoo IK, Renshaw PF. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: A proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Affect Disord 99, 19-25 (2007)
  • Oriol A, Valverde D, Capellades J, Cabanas ME, Ribera JM, Arus C. In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow. MAGMA 20, 93-101 (2007)
  • Pliss L, Mazurchuk R, Spernyak JA, Patel MS. Brain MR imaging and proton MR spectroscopy in female mice with pyruvate dehydrogenase complex deficiency. Neurochem Res 32, 645-654 (2007)
  • Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, DeSouza NM. Combined used of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Am J Roentgenol 188, 91-98 (2007)
  • Spampinato MV, Smith JK, Kwock L, Ewend M, Grimme JD, Camacho DLA, Castillo M. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. Am J Roentgenol 188, 204-212 (2007)
  • Stadlbauer A, Nimsky C, Buslei R, Pinker K, Gruber S, Hammen T, Buchfelder M, Ganslandt O. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: Correlation of metabolic and histological changes at low tumor infiltration - Initial results. Invest Radiol 42, 218-223 (2007)
  • Stadlbauer A, Nimsky C, Gruber S, Moser E, Hammen T, Engelhorn T, Buchfelder M, Ganslandt O. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: A quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. Am J Neuroradiol 28, 462-469 (2007)
  • Tonon C, Vetrugno R, Lodi R, Gallassi R, Provini F, Iotti S, Plazzi G, Montagna P, Lugaresi E, Barbiroli B. Proton magnetic resonance spectroscopy study of brain metabolism in obstructive sleep apnoea syndrome before and after continuous positive airway pressure treatment. Sleep 30, 305-311 (2007)
  • Weisskopf MG, Hu H, Sparrow D, Lenkinski RE, Wright RO. Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus. Environ Health Perspect 115, 519-523 (2007)
  • 11. Indium
  • Newton JR, Miao YB, Deutscher SL, Quinn TP. Melanoma imaging with pretargeted bivalent bacteriophage. J Nucl Med 48, 429-436 (2007)
  • Sabbah EN, Kadouche J, Ellison D, Finucane C, Decaudin D, Mather SJ. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. Nucl Med Biol 34, 293-304 (2007)
  • 12. Iodine
  • Assaad T, Mavel S, Emond P, Chalon S, Drossard ML, Vergote J, Bodard S, Allouchi H, Besnard JC, Guilloteau D. Synthesis and ex vivo evaluation of aza-trozamicol analogs as SPECT radiotracers for exploration of the vesicular acetylcholine transporter. J Label Compound Radiopharm 50, 139-145 (2007)
  • Burvenich IJG, Schoonooghe S, Blanckaert P, Bacher K, Vervoort L, Coene E, Mertens N, De Vos F, Slegers G. Biodistribution and planar gamma camera imaging of 123I- and 131I-labeled F(ab′)2 and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Nucl Med Biol 34, 257-265 (2007)
  • Fonge H, Van de Putte M, Huyghe D, Bormans G, Ni Y, De Witte P, Verbruggen A. Evaluation of tumor affinity of mono-[123I]iodohypericin and mono-[123I]iodoprotohypericin in a mouse model with a RIF-1 tumor. Contrast Media Mol Imaging 2, 113-119 (2007)
  • Lokkegaard A, Werdelin LM, Regeur L, Karlsborg M, Jensen SR, Brodsgaard E, Madsen FF, Lonsdale MN, Friberg L. Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson's disease. Eur J Nucl Med Mol Imaging 34, 508-516 (2007)
  • McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study. Lancet Neurol 6, 305-313 (2007)
  • Nikolaus S, Antke C, Beu M, Kley K, Larisch R, Wirrwar A, Muller HW. In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT. Nucl Med Commun 28, 207-213 (2007)
  • Oya S, Choi SR, Kung MP, Kung HF. 5-Chloro-2-(2′-((dimethylamino)methyl)-4′-iodophenylthio) benzenamine: A new serotonin transporter ligand. Nucl Med Biol 34, 129-139 (2007)
  • Park SH, Gwon HJ, Pradeep K. Synthesis and biological evaluation of 131I-labelled pyronaridine. J Label Compound Radiopharm 50, 123-130 (2007)
  • Pinborg LH, Videbaek C, Ziebell M, Mackeprang T, Friberg L, Rasmussen H, Knudsen GM, Glenthoj BY. [123I]Epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: Implications for the use of cerebellum as a reference region. Neuroimage 34, 1450-1453 (2007)
  • Sacher J, Asenbaum S, Klein N, Geiss-Granadia T, Mossaheb N, Poetzi C, Attarbaschi T, Lanzenberger R, Spindelegger C, Rabas A, Heinze G, Dudczak R, Kasper S, Tauscher J. Binding kinetics of 123I[ADAM] in healthy controls: A selective SERT radioligand. Int J Neuropsychopharmacol 10, 211-218 (2007)
  • 14. Technetium
  • Bai JM, Hashimoto J, Ogawa K, Nakahara T, Suzuki T, Kubo A. Scatter correction based on an artificial neural network for 99mTc and 123I dual-isotope SPECT in myocardial and brain imaging. Ann Nucl Med 21, 25-32 (2007)
  • Bleeker-Rovers CP, Rennen HJJM, Boerman OC, Wymenga AB, Visser EP, Bakker JH, Van der Meer JWM, Corstens FHM, Oyen WJG. 99mTc-Labeled interleukin 8 for the scintigraphic detection of infection and inflammation: First clinical evaluation. J Nucl Med 48, 337-343 (2007)
  • Celen S, De Groot T, Balzarini J, Vunckx K, Terwinghe C, Vermaelen P, Van Berckelaer L, Vanbilloen H, Nuyts J, Mortelmans L, Verbruggen A, Bormans G. Synthesis and evaluation of a 99mTc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECT. Nucl Med Biol 34, 283-291 (2007)
  • El-Ghany EA, Amin AM, El-Kawy OA, Amin M. Technetium-99m labeling and freeze-dried kit formulation of levofloxacin (L-Flox): A novel agent for detecting sites of infection. J Label Compound Radiopharm 50, 25-31 (2007)
  • Hao GY, Zang JY, Liu BL. Preparation and biodistribution of novel 99mTc(CO)3-CNR complexes for myocardial imaging. J Label Compound Radiopharm 50, 13-18 (2007)
  • Kothari K, Prasad S, Korde A, Mukherjee A, Mathur A, Jaggi M, Venkatesh M, Pillai AMR, Mukherjee R, Ramamoorthy N. 99mTc(CO)3-VIP analogues: Preparation and evaluation as tumor imaging agent. Appl Radiat Isot 65, 382-386 (2007)
  • Liu S. Ether and crown ether-containing cationic 99mTc complexes useful as radiopharmaceuticals for heart imaging. Dalton Trans 1183-1193 (2007)
  • Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen XY, Jia B, Wang F. Evaluation of a 99mTc-labeled cyclic RGD tetramer for noninvasive imaging integrin αvβ3-positive breast cancer. Bioconjug Chem 18, 438-446 (2007)
  • Motaleb MA. Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes. J Radioanal Nucl Chem 272, 95-99 (2007)
  • Motaleb MA. Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 272, 167-171 (2007)
  • Tran T, Engfeldt T, Orlova A, Widstrom C, Bruskin A, Tolmachev V, Karlstrom AE. In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules. Bioconjug Chem 18, 549-558 (2007)
  • Zhang JB, Wang XB, Jin C. Synthesis and biodistribution of the 99mTc(CO)3-DEDT complex as a potential new radiopharmceutical for brain imaging. J Radioanal Nucl Chem 272, 91-94 (2007)
  • 15. Others
  • Blenman RAM, Port JD, Felmlee JP. Selective maximization of 31P MR spectroscopic signals of in vivo human brain metabolites at 3T. J Magn Reson Imaging 25, 628-634 (2007)
  • Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Shin IS, Paik CH, Choyke PL, Kobayashi H. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res 67, 2791-2799 (2007)
  • Hsu AR, Cai WB, Veeravagu A, Mohamedali KA, Chen K, Kim S, Vogel H, Hou LC, Tse V, Rosenblum MG, Chen XY. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med 48, 445-454 (2007)
  • Kim HM, Yang PR, Seo MS, Yi JS, Hong JH, Jeon SJ, Ko YG, Lee KJ, Cho BR. Magnesium ion selective two-photon fluorescent probe based on a benzo[h]chromene derivative for in vivo imaging. J Org Chem 72, 2088-2096 (2007)
  • McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106, 660-666 (2007)
  • Moghadam FH, Jalilian AR, Nemati A, Abedini M. Preparation and biodistribution studies of [67Ga]2-acetylpyridine 4,4-dimethyl thiosemicarbazone complex as a possible SPECT tracer for detection of malignancies. J Radioanal Nucl Chem 272, 115-121 (2007)
  • Mulder WJM, Van Der Schaft DWJ, Hautvast PAI, Strijkers GJ, Koning GA, Storm G, Mayo KH, Griffioen AW, Nicolay K. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J 21, 378-383 (2007)
  • Smesny S, Rosburg T, Nenadic I, Fenk KP, Kunstmann S, Rzanny R, Volz HP, Sauer H. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia. Neuroimage 35, 729-737 (2007)
  • Sohya K, Kameyama K, Yanagawa Y, Obata K, Tsumoto T. GABAergic neurons are less selective to stimulus orientation than excitatory neurons in layer II/III of visual cortex, as revealed by in vivo functional Ca2+ imaging in transgenic mice. J Neurosci 27, 2145-2149 (2007)